Welcome to LookChem.com Sign In|Join Free
  • or
4-((3,4-dioxo-3,4-dihydronaphthalen-1-yl)amino)benzenesulfonic acid is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

758650-60-1

Post Buying Request

758650-60-1 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

758650-60-1 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 758650-60-1 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 7,5,8,6,5 and 0 respectively; the second part has 2 digits, 6 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 758650-60:
(8*7)+(7*5)+(6*8)+(5*6)+(4*5)+(3*0)+(2*6)+(1*0)=201
201 % 10 = 1
So 758650-60-1 is a valid CAS Registry Number.

758650-60-1Downstream Products

758650-60-1Relevant academic research and scientific papers

Discovery of Small-Molecule Inhibitors of the HSP90-Calcineurin-NFAT Pathway against Glioblastoma

Liu, Zhenzhen,Li, Hongli,He, Lian,Xiang, Yu,Tian, Chengsen,Li, Can,Tan, Peng,Jing, Ji,Tian, Yanpin,Du, Lupei,Huang, Yun,Han, Leng,Li, Minyong,Zhou, Yubin

, p. 352 - 7,365 (2019)

Glioblastoma (GBM) is among the most common and malignant types of primary brain tumors in adults, with a dismal prognosis. Although alkylating agents such as temozolomide are widely applied as the first-line treatment for GBM, they often cause chemoresis

1,2- two alkone naphthalene compound and its preparation method and application

-

Paragraph 0065; 0066; 0067, (2017/02/24)

The invention discloses a 1,2-diketone naphthalene compound which has a general structural formula (I) described in the specification, wherein Ar represents benzene ring, naphthalene ring, quinoline ring or isoquinoline ring, naphthalene diimide ring or coumarin ring; amino acid is directly connected with the Ar; when a substituent group exists on the Ar, R is an electron-withdrawing, electron-donating or neutral group. The invention further discloses a preparation method of the compound and application of the compound to preparation of inflammation-resistant and immunocompetence-resistant drugs. The compound is relatively good in inflammation and immunological competence resistance, is a CRAC (Ca release activated Ca) blocker with a novel structure, and can be used as a lead compound of the inflammation-resistant and immunocompetence-resistant drugs. According to the preparation method, the reaction condition is mild, raw materials are cheap and easily available, and the operation and the post-treatment process are simple.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 758650-60-1